A major move is in the offing as Annovis Bio Inc (ANVS) market cap hits 53.21 million

On Friday, Annovis Bio Inc (NYSE: ANVS) opened higher 5.00% from the last session, before settling in for the closing price of $2.60. Price fluctuations for ANVS have ranged from $2.44 to $20.00 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted 68.51% at the time writing. With a float of $15.51 million, this company’s outstanding shares have now reached $19.49 million.

The firm has a total of 6 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.

Annovis Bio Inc (ANVS) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Annovis Bio Inc is 20.40%, while institutional ownership is 13.50%.

Annovis Bio Inc (ANVS) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 68.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.17% during the next five years compared to -126.41% drop over the previous five years of trading.

Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators

Check out the current performance indicators for Annovis Bio Inc (ANVS). In the past quarter, the stock posted a quick ratio of 2.66.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.85, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.84 in one year’s time.

Technical Analysis of Annovis Bio Inc (ANVS)

Analysing the last 5-days average volume posted by the [Annovis Bio Inc, ANVS], we can find that recorded value of 0.56 million was lower than the volume posted last year of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 14.93%. Additionally, its Average True Range was 0.34.

During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 3.58%, which indicates a significant decrease from 11.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 168.36% in the past 14 days, which was higher than the 94.53% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.70, while its 200-day Moving Average is $7.31. Now, the first resistance to watch is $2.81. This is followed by the second major resistance level at $2.89. The third major resistance level sits at $2.99. If the price goes on to break the first support level at $2.63, it is likely to go to the next support level at $2.53. Should the price break the second support level, the third support level stands at $2.45.

Annovis Bio Inc (NYSE: ANVS) Key Stats

There are currently 14,236K shares outstanding in the company with a market cap of 53.21 million. Presently, the company’s annual sales total 0 K according to its annual income of -56,200 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,640 K.